Skip to main content

Table 4 Characteristics of the 15 intermediate-risk EEC patients with recurrence

From: Whether intermediate-risk stage 1A, grade 1/2, endometrioid endometrial cancer patients with lesions larger than 2 cm warrant lymph node dissection?

Group

Age range (years)

Tumor grade

Myometrial invasion

Tumor maximum diameter (mm)

Lesion location

Treatment after surgery

Interval between initial surgery and recurrence(months)

Site of recurrence

Treatment after recurrence

Outcome

Observation time (months)

 

50–55

G1

<50%

20

fundus

none

60

distant(lung involved)

chemotherapy

alive

75

 

70–75

G2

<50%

40

diffuse lesion

none

35

distant(lung involved)

palliative treatment

died of recurrence

66

LND

50–55

G1

<50%

20

side wall

none

12

local

chemotherapy + radiotherapy

alive

20

n = 6

65–70

G1

<50%

30

left cornua

none

38

local

traditional Chinese medicine

alive

41

 

65–70

G2

<50%

20

side wall

none

62

local + distant

chemotherapy

died of recurrence

126

 

60–65

G1

<50%

26

left cornua

none

23

local

radiotherapy

alive

48

 

65–70

G2

<50%

25

side wall

none

57

local + distant

unknown

died of recurrence

57

 

50–55

G1

<50%

25

side wall

chemotherapy + radiotherapy

5

local

radiotherapy

alive

85

 

50–55

G1

<50%

32

side wall

none

25

local

radiotherapy

alive

66

LND omitted

65–70

G1

<50%

24

fundus

none

34

distant

surgery

alive

47

n = 9

55–60

G1

<50%

20

left cornua

none

8

local

surgery + chemotherapy

alive

76

 

55–60

G1

<50%

50

side wall

chemotherapy

12

distant(lung involved)

chemotherapy

alive

49

 

45–50

G1

<50%

22

lower uterine segment

chemotherapy

12

distant

chemotherapy

died of recurrence

99

 

65–70

G2

<50%

30

side wall

none

8

distant

chemotherapy

died of recurrence

43

 

65–70

G2

none

50

right cornua

none

7

distant

chemotherapy

died of recurrence

30

  1. LND lymph node dissection